Passage Bio, Inc. - stock earnings
PASG Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q3 | -27.1 million USD | ? USD |
2023Q2 | -23.9 million USD | ? USD |
2023Q1 | -32.8 million USD | ? USD |
2022Q4 | -25.9 million USD | ? USD |
2022Q3 | -25.9 million USD | ? USD |
2022Q2 | -39.3 million USD | ? USD |
2022Q1 | -42.8 million USD | ? USD |
2021Q4 | -51.2 million USD | ? USD |
2021Q3 | -46.9 million USD | ? USD |
2021Q2 | -48.4 million USD | ? USD |
2021Q1 | -38.9 million USD | ? USD |
2020Q4 | -38.9 million USD | ? USD |
2020Q3 | -28.5 million USD | ? USD |
2020Q2 | -27.2 million USD | ? USD |
2020Q1 | -17.6 million USD | ? USD |
2019Q4 | -13.2 million USD | ? USD |
2019Q3 | -11.4 million USD | ? USD |
2019Q2 | -13.4 million USD | ? USD |
2019Q1 | -7.7 million USD | ? USD |
2018Q4 | -5.8 million USD | ? USD |
PASG Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | -112.4 million USD | ? USD |
2022 | -136.9 million USD | ? USD |
2021 | -191.5 million USD | ? USD |
2020 | -111.8 million USD | ? USD |
2019 | -54.6 million USD | ? USD |
2018 | -12.8 million USD | ? USD |
PASG
Price: $1.35
52 week price:
Earnings Per Share: -1.86 USD
P/E Ratio: -0.49
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 271900
Market Capitalization: 73.4 million